View by Specialty

Headline News

View more

Johnson & Johnson acquires Proteologix, atopic dermatitis portfolio

May 19, 2024
1 min read
Save

Johnson & Johnson acquires Proteologix, atopic dermatitis portfolio

Johnson & Johnson acquires Proteologix, atopic dermatitis portfolio

Johnson & Johnson will pay $850 million to acquire the biotechnology company Proteologix Inc., the company announced in a press release.

View more Headline News
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails

Resources

View more

AI in Medicine

23007715_AIinMedicineRC_OG

Artificial intelligence is a rapidly evolving field. Learn how and why it is being applied in clinical practice in multiple medical specialties.

View resource

LGBTQ+ Health Updates

This is a collection of news articles and features that provide the latest information on the unique health needs of individuals in the LGBTQ+ community.

View resource
View more Resources
View more Meeting News

Upcoming Meetings

View meeting calendar
View meeting calendar

Blogs & Columns

View more
Joel M. Gelfand

Beneath the Surface

with Joel M. Gelfand, MD, MSCE
An exploration of hot topics in dermatology.
View more Blogs & Columns